Computational drug repurposing: approaches, evaluation of in silico resources and case studies
Z
Ziaurrehman Tanoli
A
Adrià Fernández-Torras
U
Umut Onur Özcan
A
Aleksandr Kushnir
K
Kristen Michelle Nader
Y
Yojana Gadiya
L
Laura Fiorenza
A
Aleksandr Ianevski
M
Markus Vähä-Koskela
M
Mitro Miihkinen
U
Umair Seemab
H
Henri Leinonen
B
Brinton Seashore-Ludlow
M
Marianna Tampere
A
Adelinn Kalman
F
Flavio Ballante
E
Emilio Benfenati
G
Gary Saunders
S
Swapnil Potdar
I
Ismael Gómez García
R
Ricard García-Serna
C
Carmine Talarico
A
Andrea Rosario Beccari
W
Wesley Schaal
A
Andrea Polo
S
Susan Costantini
E
Enrico Cabri
M
Marc Jacobs
J
Jani Saarela
A
Alfredo Budillon
O
Ola Spjuth
P
Päivi Östling
H
Henri Xhaard
J
Jordi Quintana
J
Jordi Mestres
P
Philip Gribbon
A
Anton E. Ussi
D
Donald C. Lo
M
Martin de Kort
K
Krister Wennerberg
M
Maddalena Fratelli
J
Jordi Carreras-Puigvert
T
Tero Aittokallio
Article Details
Journal
Nature Reviews Drug Discovery
Volume / Issue
Vol. 24, Issue 7
Published
July 01, 2025
Pages
521-542
ISSN
1474-1776
Publisher
Springer Science and Business Media LLC
Journal Info
Nature Reviews Drug Discovery
Springer Science and Business Media LLC
ISSN: 1474-1776 Q1 Medicine
Authors (43)
Z
Ziaurrehman Tanoli
A
Adrià Fernández-Torras
U
Umut Onur Özcan
A
Aleksandr Kushnir
K
Kristen Michelle Nader
Y
Yojana Gadiya
L
Laura Fiorenza
A
Aleksandr Ianevski
M
Markus Vähä-Koskela
M
Mitro Miihkinen
U
Umair Seemab
H
Henri Leinonen
B
Brinton Seashore-Ludlow
M
Marianna Tampere
A
Adelinn Kalman
F
Flavio Ballante
E
Emilio Benfenati
G
Gary Saunders
S
Swapnil Potdar
I
Ismael Gómez García
R
Ricard García-Serna
C
Carmine Talarico
A
Andrea Rosario Beccari
W
Wesley Schaal
A
Andrea Polo
S
Susan Costantini
E
Enrico Cabri
M
Marc Jacobs
J
Jani Saarela
A
Alfredo Budillon
O
Ola Spjuth
P
Päivi Östling
H
Henri Xhaard
J
Jordi Quintana
J
Jordi Mestres
P
Philip Gribbon
A
Anton E. Ussi
D
Donald C. Lo
M
Martin de Kort
K
Krister Wennerberg
M
Maddalena Fratelli
J
Jordi Carreras-Puigvert
T
Tero Aittokallio
Related Articles from this Journal
Can multispecific biologics break the efficacy ceiling?
Asher Mullard
Jul 2026
10.1038/d41573-026-00106-5
Novel drug targets in 2025
Sorin Avram, Liliana Halip et al.
Jul 2026
10.1038/d41573-026-00102-9
The unglamourous AI wins that are quietly transforming drug discovery and development
Asher Mullard
Jul 2026
10.1038/d41573-026-00099-1
Upcoming FDA approval decisions in Q3 2026
Swetha Kota
Jul 2026
10.1038/d41573-026-00103-8
Antiviral peptide nabs FDA approval for hepatitis delta virus infection
Asher Mullard
Jul 2026
10.1038/d41573-026-00101-w